J. Simard

GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo.

Sébastien Lemieux, Patrick Gendron, Tobias Herold, 2016, Blood.

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model

T. Zhang, K. Downes, D. Easton, 2022, medRxiv.

MYELOID NEOPLASIA GPR56 identi fi es primary human acute myeloid leukemia cells with high repopulating potential in vivo

G. Boucher, J. Krosl, G. Sauvageau, 2016 .

Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic target

B. Wilhelm, J. Pelloux, M. Celton, 2017, Leukemia.